Liver fibrosis: mechanisms of immune-mediated liver injury

被引:0
|
作者
Ruonan Xu
Zheng Zhang
Fu-Sheng Wang
机构
[1] Liver Disease Research Center for Biological Therapy,
[2] Beijing 302 Hospital,undefined
来源
关键词
cirrhosis; hepatic stellate cell; liver fibrosis;
D O I
暂无
中图分类号
学科分类号
摘要
Liver fibrosis and its end-stage consequence, cirrhosis, represent the final common pathway of virtually all chronic liver diseases. Research into hepatic stellate cell activation, imbalance of the extracellular matrix synthesis and degradation and the contribution of cytokines and chemokines has further elucidated the mechanisms underlying fibrosis. Furthermore, clarification of changes in host adaptive and innate immune systems has accelerated our understanding of the association between liver inflammation and fibrosis. Continued elucidation of the mechanisms of hepatic fibrosis has provided a comprehensive model of fibrosis progression and regression. This review summarizes the current concepts of improvements that have been made in the field of fibrosis.
引用
收藏
页码:296 / 301
页数:5
相关论文
共 50 条
  • [21] Effect of Plaferon LB on oxidative stress in liver tissue in immune-mediated liver injury
    Chikovani, T
    Sanikidze, T
    Sharashenidze, T
    Cheishvili, N
    Bakhutashvili, V
    ALLERGY, 2002, 57 : 71 - 71
  • [22] MECHANISMS OF IMMUNE-MEDIATED MYOCYTE INJURY
    BARRY, WH
    CIRCULATION, 1994, 89 (05) : 2421 - 2432
  • [23] Hepatic Stimulator Substance Alleviates Toxin-Induced and Immune-Mediated Liver Injury and Fibrosis in Rats
    Yi, Xuerui
    Song, Ming
    Yuan, Youcheng
    Zhang, Xinrui
    Chen, Wenyin
    Li, Jin
    Tong, Minghua
    Liu, Guangze
    You, Song
    Kong, Xiangping
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (08) : 2079 - 2087
  • [24] Hepatic Stimulator Substance Alleviates Toxin-Induced and Immune-Mediated Liver Injury and Fibrosis in Rats
    Xuerui Yi
    Ming Song
    Youcheng Yuan
    Xinrui Zhang
    Wenyin Chen
    Jin Li
    Minghua Tong
    Guangze Liu
    Song You
    Xiangping Kong
    Digestive Diseases and Sciences, 2012, 57 : 2079 - 2087
  • [25] Apoptosis in Immune-Mediated Liver Diseases
    Kahraman, Alisan
    Gerken, Guido
    Canbay, Ali
    DIGESTIVE DISEASES, 2010, 28 (01) : 144 - 149
  • [26] Immune-Mediated Therapies for Liver Cancer
    Aravalli, Rajagopal N.
    Steer, Clifford J.
    GENES, 2017, 8 (02):
  • [27] The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice
    Wang, Han
    Feng, Xinxia
    Han, Ping
    Lei, Yu
    Xia, Yujia
    Tian, Dean
    Yan, Wei
    MOLECULAR MEDICINE REPORTS, 2019, 20 (06) : 4883 - 4892
  • [28] PGAM5: a new player in immune-mediated liver injury
    Ramachandran, Anup
    Jaeschke, Hartmut
    GUT, 2017, 66 (04) : 567 - 568
  • [29] In vivo regulation of inducible NO synthase in immune-mediated liver injury in mice
    Koerber, K
    Sass, G
    Kiemer, AK
    Vollmar, AM
    Tiegs, G
    HEPATOLOGY, 2002, 36 (05) : 1061 - 1069
  • [30] The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury
    Rao, Tai
    Liu, Ya-ting
    Zeng, Xiang-chang
    Li, Chao-peng
    Ou-Yang, Dong-sheng
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (01) : 27 - 35